Depression Clinical Trial
— IpsyInsomniOfficial title:
Guided Internet-treatment for Insomnia. Treatment Effects, Health Economics and Interaction With Depression
Verified date | April 2015 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
This study includes two sub-trials.
In trial 1 patients suffering from insomnia but not meeting the criteria for depression are
randomised to either therapist guided Internet-based CBT for insomnia or to a control group
with a non-guided, brief self-help program that acts as a placebo control. The primary
purpose is to evaluate reduction in Insomnia severity (compared to placebo) after treatment
and at follow-ups at 6-month, 1 year and 3 years. Secondary purpose is to evaluate the
costeffectiveness of the treatment and to evaluate if the insomnia treatment has a
preventive effect on future depressive episodes. Recruitment is done through mass media and
includes all regions of Sweden. Initial assessment based on questionnaires and telephone
interviews.
Trial 2 includes patients suffering from both Insomnia and depression. Randomization is done
between either CBT for insomnia or CBT for depression (both Internet-based) to evaluate each
respective treatment's effect on both insomnia and depression. The patients need for further
treatment after the initial one will be measured and used as a secondary outcome.
Recruitment is done through mass media but only citizens in the Stockholm area are included
since the initial assessment are based on both questionnaires and telephone interviews as
well as a visit at a psychiatrist located at the Internet psychiatry clinic in Stockholm.
Both trials will include health economic data and analysis. For the longer follow-up periods
(1 and 3 years), registers will be used to analyse consumption of sleep medication and
antidepressants as well as general health care utilization.
Status | Completed |
Enrollment | 191 |
Est. completion date | February 2015 |
Est. primary completion date | February 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Clinical level of Insomnia (more than 10 on ISI) - Meets criteria for Insomnia according to DSM-IV-TR - Enough language skills - Only Trial 2: Meets criteria for Major Depressive Disorder according to DSM-IV-TR Exclusion Criteria: - Sleep disorders requiring other treatment - High consumption of alcohol/drugs that affect sleep - Started to use or changed the dose of antidepressant drug during the last 2 months - Somatic or psychiatric conditions requiring acute care - Working night shifts - Only Trial 1: Meets criteria for Major Depressive Disorder according to DSM-IV-TR |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska Institutet | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet | Stockholm County Council, Sweden |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Insomnia Severity Index (ISI) | 7-item, self-rated questionnaire measuring insomnia severity. Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307. | Post-treatment (9 weeks) | No |
Primary | MADRS-S | The use of two primary outcomes are motivated since the purpose is to look at effects on both insomnia and depression. In trial 1 the former is used to predict the latter, and in Trial 2 the patientents suffer from both conditions. The MADRS-S is a 9-item self-rated measure of depression severity and screens for suicidality. Mattila-Evenden, M., Svanborg, P., Gustavsson, P., & Åsberg, M. (1996). Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of CPRS. Acta Psychiatr Scand, 94, 386-396. |
Post-treatment (9 weeks) | Yes |
Primary | ISI | 6-month follow-up | No | |
Primary | ISI | 1-year follow-up | No | |
Primary | ISI | 3-years follow-up | No | |
Primary | MADRS-S | 6-month follow-up | Yes | |
Primary | MADRS-S | 1-year follow-up | Yes | |
Primary | MADRS-S | 3-years follow-up | Yes | |
Secondary | Sleep Diary | One week of self-ratings on a number of sleep parameters, resluting in measures of sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings, subjecitve sleep quality and daytime functioning | Same as primary outcomes | No |
Secondary | Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P) | Health economic questionnaire evalutation cost for health care, abscence of work capacity and related costs. Hakkaart-Van Roijen, L.,Van Straten, A., & Donker, M. (2002). Manual: Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness. Rotterdam: Erasmus University |
Same as Primary outcomes | No |
Secondary | EQ-5D | General quality of life measure to complement the TIC-P in health economic analysis. Hinz, A., Klaiberg, A., Brahler, E., & Konig, H.H. (2006). The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population. Psychother.Psychosom.Med.Psychol., 56, 42-48. |
Same as primary outcomes | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |